New Patient Appointment or 214-645-8300

Inflammatory Bowel Disease in Children

New IBD therapies take the ‘if factor’ out of Crohn’s, ulcerative colitis

Three new types of IBD medication – IL-23 selective inhibitors, S1P modulators, and JAKi agents – offer patients a chance at freedom from the disruptive symptoms of Crohn's disease and ulcerative colitis.

David Fudman, M.D.

August 19, 2025

Including families in pediatric IBD care improves patient outcomes

UT Southwestern discusses how the Inflammatory Bowel Disease Center’s Pediatric Program helps families make more informed care decisions.

Gaith Semrin, M.D.

January 4, 2022